Cytek Biosciences Stock Price Prediction

CTKB Stock  USD 6.42  0.21  3.38%   
At the present time, The relative strength index (RSI) of Cytek Biosciences' share price is at 59 suggesting that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Cytek Biosciences, making its price go up or down.

Oversold Vs Overbought

59

 
Oversold
 
Overbought
The successful prediction of Cytek Biosciences' future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Cytek Biosciences, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Cytek Biosciences' stock price prediction:
Quarterly Earnings Growth
0.658
EPS Estimate Next Quarter
0.05
EPS Estimate Current Year
0.105
EPS Estimate Next Year
0.21
Wall Street Target Price
8.4
Using Cytek Biosciences hype-based prediction, you can estimate the value of Cytek Biosciences from the perspective of Cytek Biosciences response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Cytek Biosciences to buy its stock at a price that has no basis in reality. In that case, they are not buying Cytek because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Cytek Biosciences after-hype prediction price

    
  USD 6.31  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Cytek Biosciences Basic Forecasting Models to cross-verify your projections.
For information on how to trade Cytek Stock refer to our How to Trade Cytek Stock guide.
Intrinsic
Valuation
LowRealHigh
2.257.6713.09
Details
6 Analysts
Consensus
LowTargetHigh
11.1512.2513.60
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.010.030.04
Details

Cytek Biosciences After-Hype Price Prediction Density Analysis

As far as predicting the price of Cytek Biosciences at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Cytek Biosciences or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Cytek Biosciences, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Cytek Biosciences Estimiated After-Hype Price Volatility

In the context of predicting Cytek Biosciences' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Cytek Biosciences' historical news coverage. Cytek Biosciences' after-hype downside and upside margins for the prediction period are 0.89 and 11.73, respectively. We have considered Cytek Biosciences' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
6.42
6.31
After-hype Price
11.73
Upside
Cytek Biosciences is moderately volatile at this time. Analysis and calculation of next after-hype price of Cytek Biosciences is based on 3 months time horizon.

Cytek Biosciences Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Cytek Biosciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Cytek Biosciences backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Cytek Biosciences, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.36 
5.38
  0.10 
  0.02 
8 Events / Month
3 Events / Month
In about 8 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
6.42
6.31
1.61 
1,855  
Notes

Cytek Biosciences Hype Timeline

Cytek Biosciences is currently traded for 6.42. The entity has historical hype elasticity of 0.1, and average elasticity to hype of competition of 0.02. Cytek is forecasted to increase in value after the next headline, with the price projected to jump to 6.31 or above. The average volatility of media hype impact on the company the price is over 100%. The price jump on the next news is projected to be 1.61%, whereas the daily expected return is currently at 0.36%. The volatility of related hype on Cytek Biosciences is about 8276.92%, with the expected price after the next announcement by competition of 6.44. The company reported the previous year's revenue of 193.01 M. Net Loss for the year was (12.15 M) with profit before overhead, payroll, taxes, and interest of 100.97 M. Given the investment horizon of 90 days the next forecasted press release will be in about 8 days.
Check out Cytek Biosciences Basic Forecasting Models to cross-verify your projections.
For information on how to trade Cytek Stock refer to our How to Trade Cytek Stock guide.

Cytek Biosciences Related Hype Analysis

Having access to credible news sources related to Cytek Biosciences' direct competition is more important than ever and may enhance your ability to predict Cytek Biosciences' future price movements. Getting to know how Cytek Biosciences' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Cytek Biosciences may potentially react to the hype associated with one of its peers.

Cytek Biosciences Additional Predictive Modules

Most predictive techniques to examine Cytek price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Cytek using various technical indicators. When you analyze Cytek charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Cytek Biosciences Predictive Indicators

The successful prediction of Cytek Biosciences stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Cytek Biosciences, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Cytek Biosciences based on analysis of Cytek Biosciences hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Cytek Biosciences's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Cytek Biosciences's related companies.
 2021 2022 2023 2024 (projected)
Payables Turnover16.0913.1227.5728.95
Days Of Inventory On Hand240.59278.71265.83195.16

Story Coverage note for Cytek Biosciences

The number of cover stories for Cytek Biosciences depends on current market conditions and Cytek Biosciences' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Cytek Biosciences is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Cytek Biosciences' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Cytek Biosciences Short Properties

Cytek Biosciences' future price predictability will typically decrease when Cytek Biosciences' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Cytek Biosciences often depends not only on the future outlook of the potential Cytek Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Cytek Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding135.3 M
Cash And Short Term Investments262.4 M

Complementary Tools for Cytek Stock analysis

When running Cytek Biosciences' price analysis, check to measure Cytek Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cytek Biosciences is operating at the current time. Most of Cytek Biosciences' value examination focuses on studying past and present price action to predict the probability of Cytek Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cytek Biosciences' price. Additionally, you may evaluate how the addition of Cytek Biosciences to your portfolios can decrease your overall portfolio volatility.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Stocks Directory
Find actively traded stocks across global markets
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Equity Valuation
Check real value of public entities based on technical and fundamental data